Lactate Dehydrogenase (LDH) is an enzyme that catalyzes the conversion of pyruvate, the end product of glycolysis, into lactate (and vice versa) with concomitant interconversion of NADH and NAD+.LDH is made up of two main subunits, LDH-A and LDH-B. These two subunits can combine to form LDH1, LDH2, LDH3, LDH4, and LDH5, one of five isoenzymes.
Due to its predominance in skeletal muscle, LDH-A is also known as the M subunit, and LDH-B is known as the H subunit due to its predominance in the heart. An essential metabolic enzyme called LDH-A has been linked to the growth, invasion, and metastasis of cancer. The main contributor to the Warburg effect is LDH-A. Multiple cancers' clinicopathologic traits and survival rates have been shown to correlate with LDH-A. LDH-A inhibition inhibits the proliferation of primary breast tumors. A vital glycolytic enzyme called LDH-B catalyzes the transformation of lactate and NAD+ into pyruvate, NADH, and H+. When it comes to autophagy in cancer cells, LDHB is crucial.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V120326 | 6-O-Oleoyltrehalose | 338733-38-3 | 6-O-oleoyl trehalose is a derivative of trehalose. |
|
V112134 | ACS03 | 2227022-64-0 | ACS03 is a thiophene-acridine hybrid compound. |
|
V110878 | Antibacterial agent 306 | Antimicrobial agent 306 (compound 8c) is a lactate dehydrogenase inhibitor with potent antimicrobial activity, especially effective against Gram-positive bacteria. | |
|
V73842 | Anticancer agent 121 | 2924532-47-6 | Anticancer agent 121 is a human lactate dehydrogenase A enzyme inhibitor (hLDHA) with good anti-cancer activity and may be utilized in antitumor research. |
|
V73847 | Anticancer agent 122 | 2924532-50-1 | Anticancer agent 122 is a human lactate dehydrogenase A enzyme inhibitor (hLDHA) with good anti-cancer activity and may be utilized in antitumor research. |
|
V77222 | AXKO-0046 dihydrochloride | AXKO-0046 di-HCl, an indole analogue, is a selective inhibitor of LDHB. | |
|
V116109 | Bisadinrone A | 2871811-08-2 | Bisadione A is a sesquiterpene found in turmeric (Curcuma longa). |
|
V73843 | CHK-336 | 2743436-86-2 | CHK-336 (Example 1) is an orally bioavailable LDHA inhibitor (IC50<1 nM), which can inhibit lactate production in mouse hepatocytes. |
|
V73845 | D-Lactate dehydrogenase (D-LDH) | 9028-36-8 | D-Lactate dehydrogenase (D-LDH) is an oxidoreductase that uses NAD+ or NADP+ as an acceptor and acts on the donor CH-OH group. |
|
V109975 | D-Lactic Dehydrogenase, Staphylococcus epidermidis | Staphylococcus epidermidis D-lactate dehydrogenase (EC 1.1.1.28) catalyzes the conversion of D-lactate to D-pyruvate, while simultaneously reducing NAD+ to NADH and H+. | |
|
V109200 | Dual GO/LDHA-IN-1 | Dual GO/LDHA-IN-1 is an orally effective dual-target glycolate oxidase (GO)/lactate dehydrogenase A (LDHA) inhibitor with Ki values of 390 nM and 40 nM, respectively. | |
|
V21444 | FX11 | 213971-34-7 | FX-11 is a novel, potent and selective lactate dehydrogenase A (LDHA) inhibitor with anticancer activity. |
|
V73840 | GNE-140 racemate | 1802977-61-2 | GNE-140 racemate is a racemic mixture (racemate) of (R)-GNE-140 and (S)-GNE-140. |
|
V3951 | GSK2837808A | 1445879-21-9 | GSK2837808A is a potent, selective, andan NADH-competitiveinhibitor of lactate dehydrogenase A (LDHA) withIC50s of 1.9 and 14 nM for LDHA and LDHB, respectively. |
|
V110226 | L-Lactate Dehydrogenase, Porcine | L-lactate dehydrogenase, also known as porcine lactate dehydrogenase, is an enzyme found in almost all living cells (animals, plants, and prokaryotes). | |
|
V109886 | L-Lactic Dehydrogenase, Porcine | Porcine L-lactate dehydrogenase (EC 1.1.1.27) is an enzyme found in almost all living cells (animals, plants, and prokaryotes). | |
|
V109971 | Lactate Dehydrogenase, Porcine | Porcine lactate dehydrogenase (EC 1.1.1.27) is a natural porcine lactate dehydrogenase used to study lactate metabolism and enzymatic mechanisms. | |
|
V104239 | LDH-IN-3 | LDH-IN-3 (compound E38) is an inhibitor of lactate dehydrogenase (LDH) and a potential protective agent against ischemic neurological damage in the eye and brain. | |
|
V115944 | LDH-IN-5 | 2768522-31-0 | LDH-IN-5 is a lactate dehydrogenase (LDH) inhibitor with neuroprotective effects. |
|
V116677 | LDHA-IN-10 | LDHA-IN-10 (compound HP19) is a lactate dehydrogenase A (LDHA) inhibitor with an IC50 value of 5.2 μM. |